At a glance
ClinicalIndex Comparison RecordN/ACompleted· 282 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Spain
In Brief
An observational study evaluating No Intervention for Multiple Myeloma. Completed, enrolled 282 participants across 30 sites.
Detailed Summary
The purpose of this study is to characterize the multiple myeloma (MM) participants with symptomatic relapse and/or refractory disease in Spain.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Myeloma
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartJul 2017
Primary CompletionNov 2018
Study CompletionJan 2019
TodayJul 2026
First PostedJun 15, 2017
Enrollment StartJul 26, 2017
Primary CompletionNov 15, 2018
Study CompletionJan 30, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.0 years ago
Interventions
No Interventionother
As it was an observational study, no intervention was administered in this study.